ZENOTECHPharmaceuticals

Zenotech Laboratories LtdQuarterly Results & Earnings

34.29
-5.60%
Profit Growth YoY-224.14%Latest quarter
Sales Growth YoY14.94%Latest quarter
Sales CAGR 5Y10.59%5 year compound
Profit CAGR 5Y0.36%5 year compound
📋

Quarterly Performance

YoY Profit Growth-224.14%
🔴 Significant decline
YoY Sales Growth+14.94%
✅ Strong growth
OPM 5Y Average
Operating profit margin
41.01%
EPS Growth 5Y
0.36%
Interest Coverage
Higher = safer debt servicing
N/A
ROE
4.81%
ROCE
9.40%
💡

Growth Analysis

Zenotech Laboratories Ltd reported YoY profit growth of -224.14% and revenue growth of 14.94% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 10.59% and profits at 0.36% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.